THRIVENT FINANCIAL FOR LUTHERANS - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$644
-55.1%
129,535
-55.4%
0.00%
-66.7%
Q1 2023$1,435
-50.1%
290,507
-36.4%
0.00%
-57.1%
Q4 2022$2,874
-99.8%
456,876
+174.3%
0.01%
+40.0%
Q3 2022$1,799,000
+264.2%
166,590
+283.7%
0.01%
+400.0%
Q2 2022$494,000
-33.2%
43,414
-46.6%
0.00%0.0%
Q1 2022$740,000
-68.3%
81,287
-48.0%
0.00%
-75.0%
Q4 2021$2,333,000
+67.6%
156,339
+188.6%
0.00%
+33.3%
Q3 2021$1,392,000
+29.0%
54,179
+31.0%
0.00%
+50.0%
Q2 2021$1,079,00041,3550.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders